ESC 365 - Baseline characteristics and 6-month echocardiographic assessment of chamber size in the REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure Trial: the first HFpEF device trial.

ESC Premium Access

Baseline characteristics and 6-month echocardiographic assessment of chamber size in the REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure Trial: the first HFpEF device trial.

Session: Poster session 3 - Heart failure

Topic: Heart failure, other

Speaker: Doctor F. Silvestry (Philadelphia, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Frank E Silvestry

University of Pennsylvania, Philadelphia (United States of America)

0 follower

48 more presentations in this session

Vitamin D deficiency increases risk of heart failure: prospective results from the moli-sani study

Speaker: Doctor S. Costanzo (Rome, IT)

Association between renal resistance index and one year worsening of renal function in chronic heart failure outpatients

Speaker: Associate Professor M. Iacoviello (Foggia, IT)

The neuro-mechanical unloading therapy for acute myocardial ischemia markedly reduces infarct size and prevents heart failure in the long term

Speaker: Doctor T. Arimura (Fukuoka, JP)

SGLT1 participates in cardiac remodeling in pressure-overload-induced cardiomyopathy.

Speaker: Doctor N. Matsushita (Yahabacho, JP)

Signature of both endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction

Speaker: Professor A. Berezin (Salzburg, AT)

Access the full session

Poster session 3 - Heart failure

Speakers: Doctor F. Silvestry, Doctor S. Costanzo, Associate Professor M. Iacoviello, Doctor T. Arimura, Doctor N. Matsushita...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources